Clinical Trial Results:
A 2-year, Randomized, Double-blind, Placebo-controlled, Multi-center,
Phase II-III Study to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and
80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy
Summary
|
|
EudraCT number |
2008-002843-18 |
Trial protocol |
GB HU EE BE |
Global completion date |
10 Jan 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 Dec 2016
|
First version publication date |
21 Dec 2016
|
Other versions |
|
Summary report(s) |
AS3201-G000-291 Polydefkis 2015 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.